• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

系统性红斑狼疮患者疲劳的最佳管理:系统评价。

Optimal management of fatigue in patients with systemic lupus erythematosus: a systematic review.

机构信息

Department of Occupational Therapy, School of Health Professions, University of Alabama at Birmingham, Birmingham, AL, USA.

Division of Rheumatology and Immunology, Department of Medicine, Medical University of South Carolina, SC, USA.

出版信息

Ther Clin Risk Manag. 2014 Oct 1;10:775-86. doi: 10.2147/TCRM.S56063. eCollection 2014.

DOI:10.2147/TCRM.S56063
PMID:25328393
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4199565/
Abstract

Among the host of distressing pathophysiological and psychosocial symptoms, fatigue is the most prevalent complaint in patients with systemic lupus erythematosus (SLE). This review is to update the current findings on non-pharmacological, pharmacological, and modality strategies to manage fatigue in patients with SLE and to provide some recommendations on optimal management of fatigue based on the best available evidence. We performed a systematic literature search of the PubMed and Scopus databases to identify publications on fatigue management in patients with SLE. Based on the studies reported in the literature, we identified nine intervention strategies that have the potential to alleviate fatigue in patients with SLE. Of the nine strategies, aerobic exercise and belimumab seem to have the strongest evidence of treatment efficacy. N-acetylcysteine and ultraviolet-A1 phototherapy demonstrated low-to-moderate levels of evidence. Psychosocial interventions, dietary manipulation (low calorie or glycemic index diet) aiming for weight loss, vitamin D supplementation, and acupuncture all had weak evidence. Dehydroepiandrosterone is not recommended due to a lack of evidence for its efficacy. In addition to taking treatment efficacy and side effects into consideration, clinicians should consider factors such as cost of treatment, commitments, and burden to the patient when selecting fatigue management strategies for patients with SLE. Any comorbidities, such as psychological distress, chronic pain, sleep disturbance, obesity, or hypovitaminosis D, associated with fatigue should be addressed.

摘要

在系统性红斑狼疮(SLE)患者众多令人痛苦的病理生理和心理社会症状中,疲劳是最常见的主诉。本篇综述旨在更新目前关于非药物、药物和方法策略在 SLE 患者疲劳管理中的应用,并根据现有最佳证据为疲劳的最佳管理提供一些建议。我们对 PubMed 和 Scopus 数据库进行了系统的文献检索,以确定 SLE 患者疲劳管理方面的文献。根据文献中报告的研究,我们确定了 9 种有潜力缓解 SLE 患者疲劳的干预策略。在这 9 种策略中,有氧运动和贝利尤单抗似乎具有最强的治疗效果证据。N-乙酰半胱氨酸和紫外线 A1 光疗具有低至中等水平的证据。心理社会干预、旨在减肥的饮食控制(低热量或血糖指数饮食)、维生素 D 补充剂和针灸都有较弱的证据。由于缺乏疗效证据,不推荐使用脱氢表雄酮。除了考虑治疗效果和副作用外,临床医生在为 SLE 患者选择疲劳管理策略时,还应考虑治疗成本、患者的承诺和负担等因素。任何与疲劳相关的合并症,如心理困扰、慢性疼痛、睡眠障碍、肥胖或维生素 D 缺乏症,都应得到解决。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1102/4199565/3d3b306f274f/tcrm-10-775Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1102/4199565/3d3b306f274f/tcrm-10-775Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1102/4199565/3d3b306f274f/tcrm-10-775Fig1.jpg

相似文献

1
Optimal management of fatigue in patients with systemic lupus erythematosus: a systematic review.系统性红斑狼疮患者疲劳的最佳管理:系统评价。
Ther Clin Risk Manag. 2014 Oct 1;10:775-86. doi: 10.2147/TCRM.S56063. eCollection 2014.
2
Interventions for fatigue and weight loss in adults with advanced progressive illness.针对患有晚期进行性疾病的成年人疲劳和体重减轻的干预措施。
Cochrane Database Syst Rev. 2012 Jan 18;1:CD008427. doi: 10.1002/14651858.CD008427.pub2.
3
Efficacy of lifestyle interventions in the management of systemic lupus erythematosus: a systematic review of the literature.生活方式干预在系统性红斑狼疮管理中的疗效:文献系统评价。
Rheumatol Int. 2024 May;44(5):765-778. doi: 10.1007/s00296-024-05548-x. Epub 2024 Mar 7.
4
Effectiveness of Nonpharmacologic Interventions for Decreasing Fatigue in Adults With Systemic Lupus Erythematosus: A Systematic Review.非药物干预对减轻系统性红斑狼疮成人患者疲劳的有效性:一项系统综述。
Arthritis Care Res (Hoboken). 2016 Jan;68(1):141-8. doi: 10.1002/acr.22675.
5
Diet and Systemic Lupus Erythematosus (SLE): From Supplementation to Intervention.饮食与系统性红斑狼疮(SLE):从补充到干预。
Int J Environ Res Public Health. 2022 Sep 20;19(19):11895. doi: 10.3390/ijerph191911895.
6
Patient- and Physician-reported Satisfaction With Systemic Lupus Erythematosus Treatment in US Clinical Practice.美国临床实践中患者和医生报告的系统性红斑狼疮治疗满意度
Clin Ther. 2017 Sep;39(9):1811-1826. doi: 10.1016/j.clinthera.2017.07.039. Epub 2017 Aug 10.
7
Fatigue, health-related quality of life and other patient-reported outcomes in systemic lupus erythematosus.系统性红斑狼疮的疲劳、健康相关生活质量和其他患者报告结局。
Best Pract Res Clin Rheumatol. 2013 Jun;27(3):363-75. doi: 10.1016/j.berh.2013.07.009.
8
Fatigue in Systemic Lupus Erythematosus: An Update on Its Impact, Determinants and Therapeutic Management.系统性红斑狼疮中的疲劳:关于其影响、决定因素及治疗管理的最新进展
J Clin Med. 2021 Sep 3;10(17):3996. doi: 10.3390/jcm10173996.
9
A Transcultural Perspective of Systemic Lupus Erythematosus-Related Fatigue: Systematic Review and Narrative Synthesis.系统性红斑狼疮相关疲劳的跨文化视角:系统评价与叙述性综合分析
Asian Pac Isl Nurs J. 2022 Sep 15;6(1):e39132. doi: 10.2196/39132.
10
Exercise therapy in patients with idiopathic inflammatory myopathies and systemic lupus erythematosus - A systematic literature review.特发性炎性肌病和系统性红斑狼疮患者的运动疗法——系统文献回顾。
Best Pract Res Clin Rheumatol. 2020 Apr;34(2):101547. doi: 10.1016/j.berh.2020.101547. Epub 2020 Aug 17.

引用本文的文献

1
The Interconnection Between Systemic Lupus Erythematosus and Diet: Unmet Needs, Available Evidence, and Guidance-A Patient-Driven, Multistep-Approach Study.系统性红斑狼疮与饮食之间的关联:未满足的需求、现有证据及指导——一项患者驱动的多步骤方法研究
Nutrients. 2024 Nov 29;16(23):4132. doi: 10.3390/nu16234132.
2
Exercise as adjunctive therapy for systemic lupus erythematosus.运动作为系统性红斑狼疮的辅助治疗。
Cochrane Database Syst Rev. 2023 Apr 19;4(4):CD014816. doi: 10.1002/14651858.CD014816.pub2.
3
Gut microbiota in SLE: from animal models to clinical evidence and pharmacological perspectives.

本文引用的文献

1
Epratuzumab for patients with moderate to severe flaring SLE: health-related quality of life outcomes and corticosteroid use in the randomized controlled ALLEVIATE trials and extension study SL0006.依帕珠单抗治疗中重度活动期狼疮性肾炎的随机对照 ALLEVIATE 试验及其扩展研究 SL0006 中的健康相关生活质量结局和皮质类固醇使用
Rheumatology (Oxford). 2014 Mar;53(3):502-11. doi: 10.1093/rheumatology/ket378. Epub 2013 Nov 22.
2
Fatigue, health-related quality of life and other patient-reported outcomes in systemic lupus erythematosus.系统性红斑狼疮的疲劳、健康相关生活质量和其他患者报告结局。
Best Pract Res Clin Rheumatol. 2013 Jun;27(3):363-75. doi: 10.1016/j.berh.2013.07.009.
3
系统性红斑狼疮中的肠道微生物群:从动物模型到临床证据和药理学视角。
Lupus Sci Med. 2023 Feb;10(1). doi: 10.1136/lupus-2022-000776.
4
Effects of diet on the outcomes of rheumatic and musculoskeletal diseases (RMDs): systematic review and meta-analyses informing the 2021 EULAR recommendations for lifestyle improvements in people with RMDs.饮食对风湿和肌肉骨骼疾病(RMDs)结局的影响:系统评价和荟萃分析,为 2021 年 EULAR 改善 RMD 患者生活方式的建议提供信息。
RMD Open. 2022 Jun;8(2). doi: 10.1136/rmdopen-2021-002167.
5
Effects of physical exercise and body weight on disease-specific outcomes of people with rheumatic and musculoskeletal diseases (RMDs): systematic reviews and meta-analyses informing the 2021 EULAR recommendations for lifestyle improvements in people with RMDs.运动和体重对风湿和肌肉骨骼疾病患者特定疾病结局的影响:系统评价和荟萃分析,为 2021 年 EULAR 改善风湿和肌肉骨骼疾病患者生活方式的建议提供信息。
RMD Open. 2022 Mar;8(1). doi: 10.1136/rmdopen-2021-002168.
6
Plant-based dietary changes may improve symptoms in patients with systemic lupus erythematosus.植物性饮食改变可能改善系统性红斑狼疮患者的症状。
Lupus. 2022 Jan;31(1):65-76. doi: 10.1177/09612033211063795. Epub 2022 Jan 3.
7
Evidence and consensus-based recommendations for non-pharmacological treatment of fatigue, hand function loss, Raynaud's phenomenon and digital ulcers in patients with systemic sclerosis.针对系统性硬化症患者的疲劳、手部功能丧失、雷诺现象和手指溃疡的非药物治疗的证据和基于共识的推荐。
Rheumatology (Oxford). 2022 Apr 11;61(4):1476-1486. doi: 10.1093/rheumatology/keab537.
8
Psychometric properties of FACIT-Fatigue in systemic lupus erythematosus: a pooled analysis of three phase 3 randomised, double-blind, parallel-group controlled studies (BLISS-SC, BLISS-52, BLISS-76).系统性红斑狼疮患者FACIT疲劳量表的心理测量学特性:三项3期随机、双盲、平行组对照研究(BLISS-SC、BLISS-52、BLISS-76)的汇总分析
J Patient Rep Outcomes. 2021 Apr 8;5(1):33. doi: 10.1186/s41687-021-00298-x.
9
Fatigue in patients with systemic lupus erythematosus and neuropsychiatric symptoms is associated with anxiety and depression rather than inflammatory disease activity.系统性红斑狼疮和神经精神症状患者的疲劳与焦虑和抑郁有关,而与炎症性疾病活动无关。
Lupus. 2021 Jun;30(7):1124-1132. doi: 10.1177/09612033211005014. Epub 2021 Mar 28.
10
Towards a practical management of fatigue in systemic lupus erythematosus.针对系统性红斑狼疮疲劳的实用管理。
Lupus Sci Med. 2020 Nov;7(1). doi: 10.1136/lupus-2020-000441.
Oxidative stress in the pathology and treatment of systemic lupus erythematosus.
氧化应激在系统性红斑狼疮的发病机制和治疗中的作用。
Nat Rev Rheumatol. 2013 Nov;9(11):674-86. doi: 10.1038/nrrheum.2013.147. Epub 2013 Oct 8.
4
Treatment regimens, protocols, dosage, and indications for UVA1 phototherapy: facts and controversies.UVA1 光疗的治疗方案、方案、剂量和适应证:事实和争议。
Clin Dermatol. 2013 Jul-Aug;31(4):438-454. doi: 10.1016/j.clindermatol.2013.01.011.
5
Drivers of cost and health-related quality of life in patients with systemic lupus erythematosus (SLE): a Swedish nationwide study based on patient reports.系统性红斑狼疮(SLE)患者的成本和健康相关生活质量的驱动因素:基于患者报告的瑞典全国性研究。
Lupus. 2013 Jul;22(8):793-801. doi: 10.1177/0961203313491849. Epub 2013 Jun 11.
6
New biologic therapy for systemic lupus erythematosus.治疗系统性红斑狼疮的新型生物疗法。
Curr Opin Pharmacol. 2013 Jun;13(3):405-12. doi: 10.1016/j.coph.2013.04.005. Epub 2013 May 7.
7
Improvements in health-related quality of life with belimumab, a B-lymphocyte stimulator-specific inhibitor, in patients with autoantibody-positive systemic lupus erythematosus from the randomised controlled BLISS trials.在随机对照 BLISS 试验中,B 淋巴细胞刺激物特异性抑制剂贝利尤单抗可改善自身抗体阳性系统性红斑狼疮患者的健康相关生活质量。
Ann Rheum Dis. 2014 May;73(5):838-44. doi: 10.1136/annrheumdis-2012-202865. Epub 2013 Mar 22.
8
Safety profile of belimumab: pooled data from placebo-controlled phase 2 and 3 studies in patients with systemic lupus erythematosus.贝利木单抗的安全性概况:来自系统性红斑狼疮患者安慰剂对照的 2 期和 3 期研究的汇总数据。
Lupus. 2013 Feb;22(2):144-54. doi: 10.1177/0961203312469259. Epub 2012 Dec 4.
9
The effect of vitamin D supplementation on inflammatory and hemostatic markers and disease activity in patients with systemic lupus erythematosus: a randomized placebo-controlled trial.维生素 D 补充对系统性红斑狼疮患者炎症和止血标志物及疾病活动的影响:一项随机安慰剂对照试验。
J Rheumatol. 2013 Mar;40(3):265-72. doi: 10.3899/jrheum.111594. Epub 2012 Dec 1.
10
Altered redox state and apoptosis in the pathogenesis of systemic lupus erythematosus.氧化还原状态改变与系统性红斑狼疮发病机制中的细胞凋亡。
Immunobiology. 2013 Apr;218(4):620-7. doi: 10.1016/j.imbio.2012.07.030. Epub 2012 Aug 4.